References
Roskams-Edris, D., Anderson-Redick, S., Kiss, Z.H. & Illes, J. Nat. Biotechnol. 35, 119–121 (2017).
Foster, A.M. et al. US patent 9,327,069 (2006).
Wagner, T.A. et al. US patent 9,050,463 (2015).
Krueger, R. & Weiss, D. US patent 9,283,378 (2012).
Association for Molecular Pathology v. Myriad Genetics, Inc. 569 U.S. 576 (2013).
35 U.S. Code §287(c).
United States Constitution, Article I, Section 8, Clause 8.
Bonito Boats, Inc. v. Thunder Craft Boats, Inc. 489 U.S. 141 (1989).
Kewanee Oil Co. v. Bicron Corp. 416 U.S. 470 (1974).
Abramowicz, M. Vanderbilt Law Rev. 56, 115–236 (2003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kuersten, A., Wexler, A. Brain modulation and patent law. Nat Biotechnol 37, 18–19 (2019). https://doi.org/10.1038/nbt.4334
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.4334
- Springer Nature America, Inc.
This article is cited by
-
Reply to: "Brain modulation and patent law"
Nature Biotechnology (2019)